Amanote Research

Amanote Research

    RegisterSign In

PC09.05 Debate 2: Large Cell Neuroendocrine Carcinoma Should Be Treated Like NSCLC or SCLC? - SCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.120
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineOncologyRespiratory MedicinePulmonary
Date

October 1, 2018

Authors
S. Laurie
Publisher

Elsevier BV


Related search

P2.08: Gene Fusions Detected in Non-Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Commentary: Pleomorphic Carcinoma: An Aggressive Type of NSCLC That Should Be Treated Like the Others

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Transformation From NSCLC to SCLC: When Did It Happen? – Authors' Reply

The Lancet Oncology
Oncology
2015English

Pulmonary Large Cell Neuroendocrine Carcinoma

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2006English

Zweitlinientherapie Des SCLC

Im Focus Onkologie
2016English

MTE27.01 Radiotherapy in ES-SCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Basal Cell Carcinoma Should Be Excised

BMJ
2004English

Bedeutung Der Antiangiogenese Beim SCLC

Im Focus Onkologie
2017English

First-Line Atezolizumab OK'd for SCLC

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy